相关实验视频

Updated: Jun 28, 2025

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

针对复发性/耐药性B细胞恶性瘤的新型CAR T细胞疗法:2023年ASH年会的最新更新

Wenjie Zhang¹, Sumei Li², Jinlan Long¹

¹Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, 29 Xinquan Rd, Fuzhou, 350001, China.

Experimental hematology & oncology

|April 18, 2024

概括

新设计的仿真抗原受体 (CAR) T细胞疗法在治疗复发性/耐药性B细胞恶性瘤 (R/RBCM) 方面表现有前途. 研究和临床试验正在推进CAR T细胞对这些具有挑战性的癌症的安全性和有效性.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
细胞疗法细胞疗法

背景情况:

化学抗原受体 (CAR) T细胞疗法是复发性/耐药性B细胞恶性瘤 (R/RBCM) 的关键治疗方法.
目前正在进行的研究重点是提高CAR T细胞用于R/RBCM治疗的安全性和有效性.

关键词:

亚洲海2023年亚洲海 2023年通过CAR T细胞治疗治疗.复发性/耐药性B细胞恶性瘤

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...